ESC 365 - Effect of tolvaptan therapy on cardiac sympathetic nerve activity in patients with acute decompensated heart failure and preserved left ventricular ejection fraction

ESC Premium Access

Effect of tolvaptan therapy on cardiac sympathetic nerve activity in patients with acute decompensated heart failure and preserved left ventricular ejection fraction

Session: Poster session 6 - Acute heart failure (AHF)

Topic: AHF - Drug treatment

Speaker: Mr S. Tamaki (Ehime, JP)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Mr Shunsuke Tamaki

Ehime University, Ehime (Japan)

0 follower

16 more presentations in this session

Time course of a set of biomarkers during compensation of an acute heart failure episode

Speaker: Doctor J. Alvarez-Garcia (Madrid, ES)

Evaluation of hemoconcentration based a multifrequency bioelectrical impedance analysis on admission is useful risk stratification in acute decompensated heart failure

Speaker: Assistant Professor Y. Yazaki (Tokyo, JP)

Cognitive impairment in patients with heart failure, carotid occlusive disease and vascular cognitive impairment. The Heart-Brain connection study

Speaker: Ms R. Amier (Amsterdam, NL)

Nutritional status in acute decompensated heart failure was closely linked to high in-hospital mortality (from the KCHF registry)

Speaker: Associate Professor T. Kato (Kyoto, JP)

The neutrophil-to-lymphocyte ratio - A valuable competitor for NT-proBNP in predicting long-term all-cause mortality in heart failure

Speaker: Assistant Professor C. Delcea (Bucharest, RO)

Access the full session

Poster session 6 - Acute heart failure (AHF)

Speakers: Mr S. Tamaki, Doctor J. Alvarez-Garcia, Assistant Professor Y. Yazaki, Ms R. Amier, Associate Professor T. Kato...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources